Biofabri, S.L
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa (NCT04975178) | Biofabri, S.L | 2022-10-17 |
| Treatment of High-risk Non-muscle Invasive Bladder Cancer With IMUNO BGC Moreau RJ as Prophylaxis (NCT03982797) | Biofabri, S.L | 2019-05-17 |
| Dose-Defining Safety and Immunogenicity Study of MTBVAC in South African Neonates (NCT03536117) | Biofabri, S.L | 2019-02-12 |
Track Biofabri, S.L automatically
Every clearance here is in the API, with alerts when new ones post.